SoundMind Featured in New York Times Article on Ketamine Clinics

This New York Times article discusses the proliferation of ketamine infusion clinics, which vary in their provision of accompanying therapeutic support during ketamine treatment. The Times interviewed SoundMind founder Dr. Hannah McLane as a counterpoint opinion in favor of comprehensive therapeutic support during psychedelic-assisted therapy. Below are some excerpts from the article. Read the full piece here.

At SoundMind Center, a psychedelic healing center in Philadelphia that administers ketamine, a trained mental health professional works with every patient, throughout their experience, said Dr. Hannah McLane, the founder. “To really address their underlying problem you need to talk to them. You need to have a dedicated person that’s doing the therapy.’’

…“I know this movement is going to be driven by profit, but I’m really pushing people to cut their profit margins just a little bit and add more therapists,” said Dr. McLane of SoundMind. “Not having a therapist or facilitator in every room throughout is not fair to the patients.”

Previous
Previous

End of Life - Psychedelics Initiative

Next
Next

Peek Inside Philadelphia’s Psychedelics Revolution